CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer

NCT04220476 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Initiating a new study with revised Statistics.

Conditions

Breast Cancer

Interventions

RADIATION: Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
DRUG: Letrozole 2.5Mg Tab
DRUG: Palbociclib 125mg

Sponsor

Weill Medical College of Cornell University